Table 5.
Changes in the prevalence of components of metabolic syndrome based on different definitions over time from 2011 to 2015
| 2015 vs 2011 | ATP III criteria | IDF criteria/Revised ATP III criteria | CDS criteria | |||
|---|---|---|---|---|---|---|
| OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
| Central obesity | 1.439 (1.347–1.537) | < 0.0001 | 1.721 (1.629–1.818) | < 0.0001 | 1.721 (1.629–1.818) | < 0.0001 |
| Elevated TG | 1.329 (1.257–1.405) | < 0.0001 | 1.22 (1.156–1.287) | < 0.0001 | 1.329 (1.257–1.405) | < 0.0001 |
| Reduced HDL-C | 0.713 (0.676–0.753) | < 0.0001 | 0.731 (0.693–0.77) | < 0.0001 | 0.501 (0.47–0.534) | < 0.0001 |
| Elevated fasting plasma glucose | 0.4 (0.374–0.427) | < 0.0001 | 0.358 (0.34–0.378) | < 0.0001 | 0.485 (0.457–0.516) | < 0.0001 |
| High blood pressure | 1.101 (1.046–1.16) | 0.0003 | 0.978 (0.929–1.029) | 0.3864 | 0.978 (0.929–1.029) | 0.3864 |
ORs were adjusted for sex, residence, marital status, age group and region; TG triglycerides, HDL-C high-density lipid cholesterol, OR odds ratio, CI confidence interval